Financing
Proceeds From The Exercise Of Stock Options And Excess Tax Benefits
Johnson & Johnson Proceeds From The Exercise Of Stock Options And Excess Tax Benefits decreased by 26.1% to $1.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 160.4%, from $450.00M to $1.17B. Over 4 years (FY 2021 to FY 2025), Proceeds From The Exercise Of Stock Options And Excess Tax Benefits shows an upward trend with a 34.8% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2010
Last reportedQ1 2026Apr 22, 2026
How to read this metric
An increase suggests higher employee participation in stock plans or higher stock prices, while a decrease may indicate lower exercise activity.
Detailed definition
This represents the cash inflows received by the company from employees exercising vested stock options and the associat...
Peer comparison
Common across large-cap companies with significant equity-based compensation plans.
Metric ID:
financing_proceeds_from_exercise_of_stock_options_and_ex_332c24Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $307.00M | $265.00M | $228.00M | $321.00M | $499.00M | $87.00M | $422.00M | -$11.00M | $265.00M | $653.00M | $187.00M | $195.00M | $95.00M | $424.00M | $124.00M | $450.00M | $107.00M | $1.27B | $1.59B | $1.17B |
| QoQ Change | — | -13.7% | -14.0% | +40.8% | +55.5% | -82.6% | +385.1% | -102.6% | >999% | +146.4% | -71.4% | +4.3% | -51.3% | +346.3% | -70.8% | +262.9% | -76.2% | >999% | +24.6% | -26.1% |
| YoY Change | — | — | — | — | +62.5% | -67.2% | +85.1% | -103.4% | -46.9% | +650.6% | -55.7% | >999% | -64.2% | -35.1% | -33.7% | +130.8% | +12.6% | +200.5% | >999% | +160.4% |
Range-$11.00M – $1.59B
CAGR+32.6%
Avg YoY Growth+246.8%
Median YoY Growth+37.6%
Proceeds From The Exercise Of Stock Options And Excess Tax Benefits at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's proceeds from the exercise of stock options and excess tax benefits?
- Johnson & Johnson (JNJ) reported proceeds from the exercise of stock options and excess tax benefits of $1.17B in Q1 2026.
- How has Johnson & Johnson's proceeds from the exercise of stock options and excess tax benefits changed year-over-year?
- Johnson & Johnson's proceeds from the exercise of stock options and excess tax benefits increased by 160.4% year-over-year, from $450.00M to $1.17B.
- What is the long-term trend for Johnson & Johnson's proceeds from the exercise of stock options and excess tax benefits?
- Over 4 years (2021 to 2025), Johnson & Johnson's proceeds from the exercise of stock options and excess tax benefits has grown at a 34.8% compound annual growth rate (CAGR), from $1.04B to $3.42B.
- What does proceeds from the exercise of stock options and excess tax benefits mean?
- Cash received from employees exercising stock options plus the tax benefits gained from those exercises.